Skye C. Mayo, M.D., M.P.H., FACS

Skye C. Mayo, M.D., M.P.H., FACS, is a Professor of Surgery in the Division of Surgical Oncology at Oregon Health & Science University (OHSU) School of Medicine, where he serves as Director of Hepatic Arterial Infusion for Advanced Liver Malignancies at the OHSU Knight Cancer Institute. His research focuses on gastrointestinal surgical oncology, including hepatic arterial infusion pump therapy for liver metastases, neoadjuvant treatment strategies for pancreatic and rectal cancer, and long-term outcomes in gastrointestinal stromal tumors (GIST). He recently led the Phase Ib FIERCE study of neoadjuvant trifluridine/tipiracil with radiation in rectal cancer and contributed to international consensus guidelines for establishing hepatic arterial infusion programs. His work has appeared in JAMA Oncology and the Journal of Clinical Oncology, and he maintains active international collaborations in GIST and hepatobiliary oncology.